Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu, Manabu Fuchikami, Jason M. Dwyer, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 11, pp. 2268-2277
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman, George K. Aghajanian, Gerard Sanacora, et al.
Nature Medicine (2016) Vol. 22, Iss. 3, pp. 238-249
Open Access | Times Cited: 1351
Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 895
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Marko Peltoniemi, Nora Hagelberg, Klaus T. Olkkola, et al.
Clinical Pharmacokinetics (2016) Vol. 55, Iss. 9, pp. 1059-1077
Closed Access | Times Cited: 513
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough, Chadi G. Abdallah, Sanjay J. Mathew
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 7, pp. 472-486
Closed Access | Times Cited: 412
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Annual Review of Medicine (2014) Vol. 66, Iss. 1, pp. 509-523
Open Access | Times Cited: 366
GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
Oliver H. Miller, Lingling Yang, Chih-Chieh Wang, et al.
eLife (2014) Vol. 3
Open Access | Times Cited: 324
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 286
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Caroline A. Browne, Irwin Lucki
Frontiers in Pharmacology (2013) Vol. 4
Open Access | Times Cited: 275
Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
Manabu Fuchikami, Alexandra M. Thomas, Rongjian Liu, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 26, pp. 8106-8111
Open Access | Times Cited: 255
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman, Ronald S. Duman
Neuroscience Letters (2015) Vol. 601, pp. 20-29
Open Access | Times Cited: 241
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
Níall Lally, Allison C. Nugent, David A. Luckenbaugh, et al.
Translational Psychiatry (2014) Vol. 4, Iss. 10, pp. e469-e469
Open Access | Times Cited: 239
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections
Ronald S. Duman
Dialogues in Clinical Neuroscience (2014) Vol. 16, Iss. 1, pp. 11-27
Open Access | Times Cited: 235
NEUROBIOLOGY OF STRESS, DEPRESSION, AND RAPID ACTING ANTIDEPRESSANTS: REMODELING SYNAPTIC CONNECTIONS
Ronald S. Duman
Depression and Anxiety (2014) Vol. 31, Iss. 4, pp. 291-296
Open Access | Times Cited: 196
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Nicolas D. Iadarola, Mark J. Niciu, Erica M. Richards, et al.
Therapeutic Advances in Chronic Disease (2015) Vol. 6, Iss. 3, pp. 97-114
Open Access | Times Cited: 188
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Ronald S. Duman
F1000Research (2018) Vol. 7, pp. 659-659
Open Access | Times Cited: 177
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Chadi G. Abdallah, Thomas G. Adams, Benjamin Kelmendi, et al.
Depression and Anxiety (2016) Vol. 33, Iss. 8, pp. 689-697
Open Access | Times Cited: 175
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 163
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 154
A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action
Marie Naughton, Gerard Clarke, Olivia F. O’Leary, et al.
Journal of Affective Disorders (2013) Vol. 156, pp. 24-35
Closed Access | Times Cited: 173
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder
Blynn G. Bunney, J Z Li, David Walsh, et al.
Molecular Psychiatry (2014) Vol. 20, Iss. 1, pp. 48-55
Open Access | Times Cited: 171
Identifying fast-onset antidepressants using rodent models
Marcia J. Ramaker, Stephanie C. Dulawa
Molecular Psychiatry (2017) Vol. 22, Iss. 5, pp. 656-665
Open Access | Times Cited: 163
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto, Manoela V. Fogaça, Rong-Jian Liu, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 1, pp. 297-302
Open Access | Times Cited: 160
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
Domenico De Berardis, Michele Fornaro, Alessandro Valchera, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2888-2888
Open Access | Times Cited: 159
The 5-HT1A receptor: Signaling to behavior
Paul R. Albert, Faranak Vahid-Ansari
Biochimie (2018) Vol. 161, pp. 34-45
Closed Access | Times Cited: 158
Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds
Mark J. Niciu, Ioline D. Henter, David A. Luckenbaugh, et al.
The Annual Review of Pharmacology and Toxicology (2014) Vol. 54, Iss. 1, pp. 119-139
Open Access | Times Cited: 155
Page 1 - Next Page

Scroll to top